X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (613) 613
Book Review (30) 30
Book / eBook (14) 14
Newsletter (3) 3
Newspaper Article (2) 2
Publication (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
pharmacotherapy (343) 343
humans (336) 336
pharmacology & pharmacy (282) 282
medicine & public health (276) 276
pharmacology/toxicology (225) 225
internal medicine (222) 222
toxicology (185) 185
index medicus (180) 180
pharmacokinetics (118) 118
drug therapy (116) 116
treatment outcome (86) 86
dosage and administration (81) 81
randomized controlled trials as topic (81) 81
adis drug evaluations (71) 71
care and treatment (71) 71
pharmacodynamics (71) 71
research (67) 67
therapeutic use (67) 67
double-blind (66) 66
efficacy (66) 66
clinical trials as topic (63) 63
usage (61) 61
adis drug profiles (58) 58
health aspects (57) 57
animals (55) 55
pharmacy (55) 55
adult (52) 52
safety (52) 52
tolerability (51) 51
management (44) 44
female (43) 43
psychiatry (39) 39
clinical trials (38) 38
oncology (36) 36
male (35) 35
neurosciences (35) 35
immunology (34) 34
neurology (34) 34
psychopharmacology (34) 34
dose-response relationship, drug (33) 33
clinical neurology (32) 32
antibodies (31) 31
biomedicine (31) 31
cancer research (31) 31
complications and side effects (31) 31
molecular medicine (31) 31
drug therapy, combination (30) 30
quality of life (30) 30
child (29) 29
adis-drug-evaluations (27) 27
patient outcomes (26) 26
administration, oral (25) 25
adolescent (25) 25
antineoplastic agents - therapeutic use (24) 24
therapy (24) 24
cancer (23) 23
diagnosis (23) 23
risk factors (23) 23
trial (23) 23
children (22) 22
cost-effectiveness (22) 22
drug administration schedule (22) 22
drug combinations (22) 22
drug interactions (22) 22
quality-of-life (22) 22
open-label (21) 21
analysis (20) 20
adis-drug-profiles (18) 18
antineoplastic agents - adverse effects (18) 18
middle aged (18) 18
pediatrics (18) 18
disease-free survival (17) 17
prevention (17) 17
aged (16) 16
clinical trials, phase iii as topic (16) 16
delayed-action preparations (16) 16
hypertension (16) 16
adis spotlights (15) 15
cardiology (15) 15
chemotherapy (15) 15
randomized controlled-trial (15) 15
diabetes mellitus, type 2 - drug therapy (14) 14
drugs (14) 14
placebo-controlled trial (14) 14
adis-clinical-q-and-a (13) 13
antibodies, monoclonal - therapeutic use (13) 13
area under curve (13) 13
hypertension - drug therapy (13) 13
in-vitro (13) 13
multicenter (13) 13
anti-bacterial agents - therapeutic use (12) 12
antihypertensive agents - therapeutic use (12) 12
antipsychotic agents - therapeutic use (12) 12
geriatrics & gerontology (12) 12
half-life (12) 12
healthy-volunteers (12) 12
pain (12) 12
pharmacoeconomics (12) 12
administration, cutaneous (11) 11
administration, inhalation (11) 11
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (10) 10
Victoria University E.J. Pratt - Stacks (6) 6
UofT at Mississauga - Stacks (4) 4
UofT at Scarborough - Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
UTL at Downsview - May be requested (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Massey College (Robertson Davies) - Rare Book (1) 1
OISE - Stacks (1) 1
Trinity College (John W Graham) - Stacks (1) 1
University College (Laidlaw) - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Drugs, ISSN 0012-6667, 12/2012, Volume 72, Issue 18, pp. 2397 - 2405
Journal Article
Drugs, ISSN 0012-6667, 04/2016, Volume 76, Issue 5, p. 605
  The MEK inhibitor cobimetinib (Cotellic®) is indicated for the treatment of patients with BRAF^sup V600^ mutation-positive unresectable or metastatic... 
Journal Article
Drugs, ISSN 0012-6667, 04/2016, Volume 76, Issue 5, pp. 605 - 605
The MEK inhibitor cobimetinib (Cotellic registered ) is indicated for the treatment of patients with BRAF super( V600) mutation-positive unresectable or... 
Journal Article
Journal Article
Journal Article
Drugs, ISSN 0012-6667, 2012, Volume 72, Issue 8, pp. 1111 - 1136
Journal Article
Drugs, ISSN 0012-6667, 10/2016, Volume 76, Issue 16, pp. 1579 - 1586
Journal Article
Drugs, ISSN 0012-6667, 04/2015, Volume 75, Issue 6, pp. 675 - 675
The single-tablet regimen of the hepatitis C virus (HCV) NS5A inhibitor ledipasvir and the HCV NS5B polymerase inhibitor sofosbuvir (ledipasvir/sofosbuvir;... 
Journal Article
Journal Article
Drugs, ISSN 0012-6667, 02/2015, Volume 75, Issue 2, pp. 197 - 197
The norepinephrine prodrug droxidopa (NORTHERA(TM)) is approved in the US for the treatment of orthostatic dizziness, lightheadedness, or the 'feeling that you... 
Journal Article
Drugs, ISSN 0012-6667, 01/2015, Volume 75, Issue 1, pp. 101 - 101
Ferric carboxymaltose (Ferinject registered , Injectafer registered ) is an intravenous iron preparation approved in numerous countries for the treatment of... 
Journal Article
Journal Article
Drugs, ISSN 0012-6667, 04/2016, Volume 76, Issue 5, pp. 605 - 615
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.